Eli Lilly

News

x-ray image of human head with brain and electric pulses

ICER says lecanemab data in Alzheimer's "inconclusive"

One of the most highly-anticipated developments in pharma next year will be the FDA's verdict on Eisai's accelerated application for lecanemab in Alzheimer's disease, due early in January.<

Healthcare

NHS Innovation and Life Sciences Commission – 2022 Report La...

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the

News

SABCS: Pharmas show their working in HR+/HER2- breast cancer

The San Antonio Breast Cancer Symposium (SABCS) has highlighted some of the most promising clinical research being undertaken by drugmakers in the category, with AstraZeneca leading the cha

News

Amgen to push latecomer obesity drug into midstage testing

Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2

News

Genomic testing 'should be offered to all cancer patients in...

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targ

Views & Analysis

Elon Musk, pharma, and the future of Twitter

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical

ICER says lecanemab data in Alzheimer's "inconclusive"

NHS Innovation and Life Sciences Commission – 2022 Report La...

SABCS: Pharmas show their working in HR+/HER2- breast cancer

Amgen to push latecomer obesity drug into midstage testing

Genomic testing 'should be offered to all cancer patients in...

Elon Musk, pharma, and the future of Twitter

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Eli Lilly

Editor's Picks